ArticleFrontiers in oncology2025
MRI-based 2.5D deep learning radiomics nomogram for the differentiation of benign versus malignant vertebral compression fractures.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Vertebral compression fractures (VCFs) represent a prevalent clinical problem, yet distinguishing acute benign variants from malignant pathological fractures constitutes a persistent diagnostic dilemma. To develop and validate a MRI-based nomogram combining clinical and deep learning radiomics (DLR) signatures for the differentiation of benign versus malignant vertebral compression fractures (VCFs). Methods: A retrospective cohort study was conducted involving 234 VCF patients, randomly allocated to training and testing sets at a 7:3 ratio. Radiomics (Rad) features were extracted using traditional Rad techniques, while 2.5-dimensional (2.5D) deep learning (DL) features were obtained using the ResNet50 model. These features were combined through feature fusion to construct deep learning radiomics (DLR) models. Through a feature fusion strategy, this study integrated eight machine learning architectures to construct a predictive framework, ultimately establishing a visualized risk assessment scale based on multimodal data (including clinical indicators and Rad features).The performance of the various models was evaluated using the receiver operating characteristic (ROC) curve. Results: The standalone Rad model using ExtraTrees achieved AUC=0.801 (95%CI:0.693-0.909) in testing, while the DL model an AUC value of 0.805 (95% CI: 0.690-0.921) in the testing cohort. Compared with the Rad model and DL model, the performance superiority of the DLR model was demonstrated. Among all these models, the DLR model that employed ExtraTrees algorithm performed the best, with area under the curve (AUC) values of 0.971 (95% CI: 0.948-0.995) in the training dataset and 0.828 (95% CI: 0.727-0.929) in the testing dataset. The performance of this model was further improved when combined with clinical and MRI features to form the DLR nomogram (DLRN), achieving AUC values of 0.981 (95% CI: 0.964-0.998) in the training dataset and 0.871 (95% CI: 0.786-0.957) in the testing dataset. Conclusion: Our study integrates handcrafted radiomics, 2.5D deep learning features, and clinical data into a nomogram (DLRN). This approach not only enhances diagnostic accuracy but also provides superior clinical utility. The novel 2.5D DL framework and comprehensive feature fusion strategy represent significant advancements in the field, offering a robust tool for radiologists to differentiate benign from malignant VCFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.